FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1644373322> ?p ?o ?g. }

• W1644373322 endingPage "165" @default.
• W1644373322 startingPage "152" @default.
• W1644373322 abstract "Therapies targeting either interleukin (IL)-23 or IL-17 have shown promise in treating T helper 17 (Th17)–driven autoimmune diseases. Although IL-23 is a critical driver of IL-17, recognition of nonredundant and independent functions of IL-23 and IL-17 has prompted the notion that dual inhibition of both IL-23 and IL-17 could offer even greater efficacy for treating autoimmune diseases relative to targeting either cytokine alone. To test this hypothesis, we generated selective inhibitors of IL-23 and IL-17 and tested the effect of either treatment alone compared with their combination in vitro and in vivo. In vitro, using a novel culture system of murine Th17 cells and NIH/3T3 fibroblasts, we showed that inhibition of both IL-23 and IL-17 completely suppressed IL-23–dependent IL-22 production from Th17 cells and cooperatively blocked IL-17–dependent IL-6 secretion from the NIH/3T3 cells to levels below either inhibitor alone. In vivo, in the imiquimod induced skin inflammation model, and in the myelin oligodendrocyte glycoprotein peptide–induced experimental autoimmune encephalomyelitis model, we demonstrated that dual inhibition of IL-17 and IL-23 was more efficacious in reducing disease than targeting either cytokine alone. Together, these data support the hypothesis that neutralization of both IL-23 and IL-17 may provide enhanced benefit against Th17 mediated autoimmunity and provide a basis for a therapeutic strategy aimed at dual targeting IL-23 and IL-17." @default.
• W1644373322 created "2016-06-24" @default.
• W1644373322 creator A5002042964 @default.
• W1644373322 creator A5006858899 @default.
• W1644373322 creator A5010883102 @default.
• W1644373322 creator A5015253176 @default.
• W1644373322 creator A5020311464 @default.
• W1644373322 creator A5026946433 @default.
• W1644373322 creator A5027383206 @default.
• W1644373322 creator A5033647081 @default.
• W1644373322 creator A5036271380 @default.
• W1644373322 creator A5040308141 @default.
• W1644373322 creator A5044920435 @default.
• W1644373322 creator A5046061783 @default.
• W1644373322 creator A5050891055 @default.
• W1644373322 creator A5053474695 @default.
• W1644373322 creator A5056987410 @default.
• W1644373322 creator A5057731792 @default.
• W1644373322 creator A5063497438 @default.
• W1644373322 creator A5069188805 @default.
• W1644373322 creator A5073329483 @default.
• W1644373322 creator A5075408945 @default.
• W1644373322 creator A5075417775 @default.
• W1644373322 creator A5077336550 @default.
• W1644373322 creator A5090215028 @default.
• W1644373322 date "2015-05-26" @default.
• W1644373322 modified "2023-10-17" @default.
• W1644373322 title "Dual Inhibition of Interleukin-23 and Interleukin-17 Offers Superior Efficacy in Mouse Models of Autoimmunity" @default.
• W1644373322 cites W1508752722 @default.
• W1644373322 cites W1543653831 @default.
• W1644373322 cites W1568265476 @default.
• W1644373322 cites W1661616496 @default.
• W1644373322 cites W1939997832 @default.
• W1644373322 cites W1979058179 @default.
• W1644373322 cites W1982078500 @default.
• W1644373322 cites W1982926364 @default.
• W1644373322 cites W1984846010 @default.
• W1644373322 cites W2006249161 @default.
• W1644373322 cites W2006522040 @default.
• W1644373322 cites W2009495078 @default.
• W1644373322 cites W2012077729 @default.
• W1644373322 cites W2016850513 @default.
• W1644373322 cites W2017987372 @default.
• W1644373322 cites W2020233428 @default.
• W1644373322 cites W2024173356 @default.
• W1644373322 cites W2024249616 @default.
• W1644373322 cites W2028493269 @default.
• W1644373322 cites W2035313919 @default.
• W1644373322 cites W2054235049 @default.
• W1644373322 cites W2063769680 @default.
• W1644373322 cites W2064645845 @default.
• W1644373322 cites W2065307318 @default.
• W1644373322 cites W2069968649 @default.
• W1644373322 cites W2078827499 @default.
• W1644373322 cites W2080705760 @default.
• W1644373322 cites W2084388036 @default.
• W1644373322 cites W2085127303 @default.
• W1644373322 cites W2087905758 @default.
• W1644373322 cites W2088569180 @default.
• W1644373322 cites W2092172066 @default.
• W1644373322 cites W2092975931 @default.
• W1644373322 cites W2093897672 @default.
• W1644373322 cites W2098913036 @default.
• W1644373322 cites W2104040734 @default.
• W1644373322 cites W2108768628 @default.
• W1644373322 cites W2112866067 @default.
• W1644373322 cites W2115073769 @default.
• W1644373322 cites W2116537360 @default.
• W1644373322 cites W2116828514 @default.
• W1644373322 cites W2126009024 @default.
• W1644373322 cites W2127592281 @default.
• W1644373322 cites W2127834887 @default.
• W1644373322 cites W2129777700 @default.
• W1644373322 cites W2132784721 @default.
• W1644373322 cites W2139008734 @default.
• W1644373322 cites W2146689487 @default.
• W1644373322 cites W2147150779 @default.
• W1644373322 cites W2151566115 @default.
• W1644373322 cites W2155779547 @default.
• W1644373322 cites W2156451877 @default.
• W1644373322 cites W2157837362 @default.
• W1644373322 cites W2162793769 @default.
• W1644373322 cites W2171541320 @default.
• W1644373322 cites W2322390243 @default.
• W1644373322 cites W2395748344 @default.
• W1644373322 cites W2776663677 @default.
• W1644373322 cites W4250753642 @default.
• W1644373322 doi "https://doi.org/10.1124/jpet.115.224246" @default.
• W1644373322 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26015463" @default.
• W1644373322 hasPublicationYear "2015" @default.
• W1644373322 type Work @default.
• W1644373322 sameAs 1644373322 @default.
• W1644373322 citedByCount "21" @default.
• W1644373322 countsByYear W16443733222015 @default.
• W1644373322 countsByYear W16443733222016 @default.
• W1644373322 countsByYear W16443733222017 @default.
• W1644373322 countsByYear W16443733222018 @default.
• W1644373322 countsByYear W16443733222019 @default.

• next